bioequivalence studies and clinical trials laboratory research

Bioequivalence Studies and Clinical Trials Services

Importance of Bioequivalence Studies and Clinical Trials

Bioequivalence studies and clinical trials play a critical role in pharmaceutical drug development and regulatory approval. These studies help demonstrate that a generic product performs the same as the reference drug in terms of safety, efficacy, and bioavailability.

Bioequivalence studies evaluate how quickly and efficiently a drug is absorbed and reaches systemic circulation. Clinical trials further assess the therapeutic performance of new medicines across different patient populations through controlled study designs.

Regulatory authorities such as the FDA, EMA, WHO, and CDSCO require scientifically robust bioequivalence studies and clinical trials before approving pharmaceutical products for market use. These studies ensure that medicines meet strict safety and quality standards.

At Regcure Pharma, we support pharmaceutical companies with comprehensive bioequivalence studies and clinical trial services aligned with international regulatory guidelines and Good Clinical Practice (GCP) standards.

A. Bio-Analytical & Bio-Equivalence (BA/BE) Studies

Ensure regulatory-ready BA/BE outcomes with scientifically rigorous, compliance-driven bioanalytical solutions. We deliver precise evaluation of bioavailability, drug absorption, and therapeutic equivalence to support fast approvals across global markets.

BA/BE Study Capabilities

  • Parallel, crossover, partial & full replicate designs
  • Long-housing & extended washout studies
  • Special population studies (geriatric, post-menopausal, etc.)
  • Multiple-dose & steady-state studies
  • Pharmacodynamic (PD) assessments

Dosage Forms & Routes

  • Oral: Tablets (IR/ER/SR/DR/MR), capsules, suspensions, granules, sublingual
  • Transdermal: Patches, creams, gels, lotions
  • Vaginal: Tablets, gels, creams
  • Inhalation & Nasal formulations
  • Rectal: Suppositories, foams
  • Injectables: IM, IV, subcutaneous

B. Clinical Trial Services (Phase I–IV)

We manage end-to-end clinical development with operational excellence and regulatory alignment, ensuring high-quality data and faster decision-making.

Clinical Research Support

  • Study design, protocol development & feasibility
  • Site identification, qualification & initiation
  • On-site & remote monitoring
  • Safety oversight & IDMC coordination
  • Case reporting, data verification & QC
  • Regulatory submissions & approvals
  • Statistical analysis & complete CSR preparation

Operational & Regulatory Support

We provide full oversight for BA/BE and clinical programs—CRO evaluation, site qualification, audit readiness, and compliance monitoring.

Submission & Post-Study Support

From BE submission to regulatory query management, we ensure smooth communication with authorities and facilitate hassle-free approval pathways.

Why chose us?

We manage everything from CRO and site verification to study execution, audits, and submission. Our team ensures clean data, fast query resolution, and regulatory-aligned documentation, giving you a seamless and compliant BA/BE journey.

Scroll to Top